Clinical Trials Directory

Trials / Terminated

TerminatedNCT00680459

Ethanol Locks for the Treatment of Central Venous Line Infections

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Baystate Medical Center · Academic / Other
Sex
All
Age
6 Months – 23 Years
Healthy volunteers
Not accepted

Summary

Ethanol Locks as an Adjunct Treatment for Central Venous Line Infections Purpose To evaluate the effectiveness of a 70% ethanol lock solution when used as an adjunct therapy with antibiotics to treat central venous line infections Study Design Randomized Controlled Trial Study Protocol Only those patients meeting all inclusion criteria and no exclusion criteria will be eligible to participate in this study. Once identified, signed informed consent will be obtained from the patient's guardian and the patient himself/herself depending on age. Patients will be randomized into 2 groups: Group 1 - those patients who will receive ethanol lock therapy and Group 2- those patients who will receive placebo therapy in the form of a heparin lock solution. Outcome Measures Treatment success as defined by- * Clearance of the infection as documented by negative blood cultures on day 6 (one day after completed of lock treatment) * Preservation of the line at 30 days post treatment (day 35 of the study), this will be documented by a chart review in CIS and telephone interview to ensure no further growth from blood cultures or infections Treatment failure as defined by- * Clinical worsening during treatment * Removal of the line due to persistent infection or sepsis * Recurrence of infection with the same pathogen within 30 days

Detailed description

Ethanol Lock Technique Protocol (adapted from the Children's Hospital Los Angeles) 1. Obtain a 3ml syringe made by the Baystate Pharmacy which will contain either sterile 70% ethanol solution or 10 units/ml heparin flush solution. Randomization into study groups will be performed by the pharmacy in patient blocks of 10. Treating physician and nurses will be blinded to patient group assignment. Syringes will be labeled "70% ethanol/heparin lock Study Solution" 2. Cleanse Hands 3. Use aseptic Technique throughout procedure 4. Clean injection cap/posi-flow cap with alcohol for 30 seconds and let dry 5. Unclamp the catheter and gently flush with normal saline to ensure patency of the catheter 6. Instill ethanol/heparin lock into the catheter to fill volume * Broviac Single Lumen 4.2 Fr (ID 0.7) Dose 0.8ml * Broviac Single Lumen 6.6 Fr (ID 1mm) Dose 0.8ml * Med-comp Single Lumen Catheter Dose 1.2ml * Hickman Double Lumen 7 Fr Distal (ID 1mm) Dose 1.2ml * Hickman Double Lumen 9 Fr Proximal (ID 0.7) Dose 1.2ml * Med-comp Double Lumen 8 or 10 Fr Dose 1.2ml * Port-a-cath- Any Port (including priming tubing) Dose 1.9ml 7. Clamp the catheter 8. Label the locked lumen with the provided label so that med is not flushed through the catheter 9. Let ethanol dwell in catheter continuously for 4 hours 10. When ethanol has dwelled for 4 hours, withdraw and discard the lock solution 11. The above procedure should be repeated daily for 5 consecutive days 12. The above procedure should be repeated to each lumen of the central venous catheter daily if there are multiple lumens

Conditions

Interventions

TypeNameDescription
DRUG70% ethanol70% ethanol lock solution instilled into central venous line of patient with documented infection, in addition to usual care with antimicrobials and supportive therapy. Volume of solution instilled varies from 0.8-1.9ml depending on volume of the lumen and hub of the particular size line being treated. 70% ethanol solution dwells for 4 hours, then is withdrawn and discarded. This procedure repeated daily for 5 consecutive days.
DRUGheparin flush solutionheparin flush (10 units/ml) lock solution instilled into central venous line of patient with documented infection, in addition to usual care with antimicrobials and supportive therapy. Volume of solution instilled varies from 0.8-1.9ml depending on volume of the lumen and hub of the particular size line being treated. Heparin lock solution dwells for 4 hours, then is withdrawn and discarded. This procedure repeated daily for 5 consecutive days.

Timeline

Start date
2008-05-01
Primary completion
2011-06-01
Completion
2011-06-01
First posted
2008-05-20
Last updated
2014-03-12
Results posted
2014-03-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00680459. Inclusion in this directory is not an endorsement.